venetoclax
Targeted Therapies
Common brand names
- Venclexta
Approved use in
- Acute Myeloid Leukemia
- B-Cell Prolymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Follicular lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Peripheral T-Cell Lymphoma
- T-Cell Prolymphocytic Leukemia
Administration method
- Oral
Information about use in Acute Myeloid Leukemia
Information about use in B-Cell Prolymphocytic Leukemia
Information about use in Blood Cancer
Information about use in Chronic Lymphocytic Leukemia
Information about use in Follicular lymphoma
Information about use in Mantle Cell Lymphoma
Information about use in Myelodysplastic Syndromes
Information about use in Multiple Myeloma
Information about use in Peripheral T-Cell Lymphoma
Information about use in T-Cell Prolymphocytic Leukemia